↓ Skip to main content

Cochrane Database of Systematic Reviews

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review

Overview of attention for article published in Cochrane database of systematic reviews, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
15 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
200 Mendeley
Title
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
Published in
Cochrane database of systematic reviews, October 2018
DOI 10.1002/14651858.cd001904.pub4
Pubmed ID
Authors

Sarah J Nevitt, Anthony G Marson, Catrin Tudur Smith

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 200 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 31 16%
Student > Bachelor 27 14%
Other 16 8%
Researcher 15 8%
Student > Postgraduate 10 5%
Other 35 18%
Unknown 66 33%
Readers by discipline Count As %
Medicine and Dentistry 45 23%
Nursing and Health Professions 23 12%
Psychology 11 6%
Biochemistry, Genetics and Molecular Biology 7 4%
Neuroscience 6 3%
Other 30 15%
Unknown 78 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2021.
All research outputs
#3,361,057
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#6,128
of 13,156 outputs
Outputs of similar age
#66,624
of 362,480 outputs
Outputs of similar age from Cochrane database of systematic reviews
#142
of 224 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.